September 2020—GenMark Diagnostics announced that its ePlex Respiratory Pathogen 2 Panel is available for U.S. commercial distribution and clinical use.
The ePlex RP2 Panel is a rapid-result multiplex panel test that can identify 21 pathogens, including SARS-CoV-2, influenza, adenovirus, rhinovirus, and respiratory syncytial virus, in less than two hours. The panel is designed for use with GenMark’s ePlex system.
The company has submitted an EUA to the Food and Drug Administration for the panel.
GenMark Diagnostics, 760-448-4300